Cargando…
The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
Metabolic syndrome (MetS), a set of metabolic risk factors including obesity, dysglycemia, and dyslipidemia, is associated with increased colorectal cancer (CRC) risk. A putative biological mechanism is chronic, low-grade inflammation, both a feature of MetS and a CRC risk factor. However, excess bo...
Autores principales: | Harlid, Sophia, Myte, Robin, Van Guelpen, Bethany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381203/ https://www.ncbi.nlm.nih.gov/pubmed/28522899 http://dx.doi.org/10.1155/2017/4803156 |
Ejemplares similares
-
A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
por: Myte, Robin, et al.
Publicado: (2020) -
Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort
por: Myte, Robin, et al.
Publicado: (2019) -
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
por: Sundkvist, Anneli, et al.
Publicado: (2019) -
Prediagnostic Prescription Antibiotics Use and Survival in Patients with Colorectal Cancer: A Swedish National Register-Based Study
por: Lu, Sai San Moon, et al.
Publicado: (2023) -
Density of CD3(+) and CD8(+) Cells in the Microenvironment of Colorectal Cancer according to Prediagnostic Physical Activity
por: Renman, David, et al.
Publicado: (2021)